JAMIE UCCI: Open Payments
NPI 1174116735 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 22 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $304 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $123 |
| Amgen Inc. | 3 | $77 |
| SI-BONE, INC. | 1 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| PFIZER INC. | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| ABBVIE INC. | 2 | $35 |
| Medtronic, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: PASCAL, Kerendia, KRYSTEXXA, TRELEGY ELLIPTA, OTEZLA, PAXLOVID, ELIQUIS, Wegovy.
Industry payments across NV — which companies pay providers there.
